GLP-1 Receptor Agonists Reduce Hyperkalemia and Enhance RASi Use in Type 2 Diabetes Dr Riya Dave1 Oct 2024 8:15 AM ISTResults of a recent study found that glucagon-like peptide-1 receptor agonists (GLP-1RAs) were associated with a lower risk for hyperkalemia, greater...
Fotagliptin, potential new approach for treatment-naive patients with type 2 diabetes Medha Baranwal20 Oct 2023 11:30 AM ISTChina: A recent study published in BMC Medicine revealed Fotagliptin, a novel DPP4 inhibitor, to be noninferior to alogliptin and significantly more...
SGLT2 inhibitors have similar fracture risk as other antidiabetics in postmenopausal women with diabetes: JAMA Medha Baranwal3 Oct 2023 11:15 AM ISTSouth Korea: A claims-based study involving two independent Korean cohorts revealed that SGLT2 inhibitors are associated with a lower or similar risk...
Are GLP1-Agonists best out of new diabetes medications for primary CVD prevention? Medha Baranwal10 May 2023 11:00 AM ISTUSA: Among diabetes patients already on insulin, metformin, or sulfonylurea treatment and without cardiovascular disease, the addition of GLP-1...
SGLT2 inhibitors reduce incident obstructive airway disease in type 2 diabetes patients Jacinthlyn Sylvia6 Feb 2023 8:00 PM ISTThe findings of a retrospective cohort study published in the Journal of American Medical Association suggests that type 2 diabetes patients in Hong...
Vildagliptin and linagliptin use associated with bullous pemphigoid Medha Baranwal12 Aug 2022 10:15 AM ISTJapan:A recent study in The Journal of Dermatology showed that dipeptidyl peptidase-4 inhibitors (DPP-4i) have been linked to cases of rare skin...
SGLT-2 inhibitors better than DPP-4 inhibitors in frail diabetes patients Dr. Hiral patel9 Aug 2022 12:00 PM ISTAustralia: Sodium-glucose cotransporter-2 inhibitors may be preferred to dipeptidyl peptidase-4 inhibitors for reducing rates of major adverse...
DPP-4 inhibitors use not linked to pneumonia in diabetics, says study Medha Baranwal28 July 2020 8:03 PM ISTItaly: The use of dipeptidyl-peptidase 4 inhibitors (DPP-4i) in people with type 2 diabetes is safe with regard to pneumonia risk, a recent study...
 DPP-4 inhibitors lower blood sugar as well as dementia risk: Study Dr. Kamal Kant Kohli8 Jun 2020 12:45 PM ISTResearchers have found in a new study that diabetes patients treated with Anti-diabetic medication DPP-4 inhibitors had lowest dementia risk. Of all...
